Healthcare artificial intelligence company Viz.ai announced that it is joining forces with Medtronic with the goal of speeding up adoption of the former’s technology. Specifically the pair will be working on getting Viz.ai’s system, which specializes on stroke detection, into more stroke treatment centers in the US.
“Medtronic is an innovative company focused on therapies that extend life and restore health,” Dr. Chris Mansi, cofounder and CEO of Viz.ai, said in a statement. “As the largest medical device company in the world, Medtronic is an ideal partner to help physicians access Viz.ai’s cutting-edge technology to ensure as many patients get the care they need as quickly as possible.”
The FDA has inked a deal with French company Dassault Systèmes extending its ongoing partnership to develop a platform, called 3DEXPERIENCE, aimed at facilitating a more efficient review of cardiovascular and medical devices. The announcement means that the two will continue the relationship for another five years, entering into the second phase of the collaboration which will use virtual patients “based on computational modeling and simulation to improve efficiency of clinical trials for new device designs.”
“Our collaboration with the FDA underscores the relevance and sustainability of digital twin experiences created with the 3DEXPERIENCE platform to test devices and drugs in scientific and medical innovation,” Claire Biot, VP of life sciences industry at Dassault Systèmes, said in a statement. “Enriching technology already well established in regulated industries such as aerospace and automotive, virtual patients support the complex development of therapies for the heart, brain and more by eliminating traditional cost and time bottlenecks. With this new review process, Dassault Systèmes and the FDA can be partners in the transformative impact of the virtual world on industrial innovation, new treatments and the patient experience.”
This morning health coaching platform Liva Healthcare struck a new deal with NHS-funded Care City, a program dedicated to using innovation to improve healthy aging. As part of the deal NHS doctors will work with the platform to create a nine-month behavioral change program for folks living with Type 2 diabetes. As part of the program, patients will get a personal coach who they can chat with over video. The app will also help them keep track of their progress.
“Patients want to take a more active role in managing their own health,” John Craig, chief executive of Care City, said in a statement. “Our partnership with Liva Healthcare responds well to exactly this need and we are excited to see what positive, long-term outcomes flourish from this collaboration.”
On Tuesday SnapMD, a telemedicine company that specializes in the enterprise market, announced a partnership with healthcare-focused plug-and-play platform Carefluence to develop a new enterprise telemedicine platform. Dubbed Virtual Care Management, the new system will integrate with the EHR software ModuleMD.
“SnapMD and Carefluence’s partnership helps to remove the barriers of technology differences that hinder collaboration and to virtually connect the care continuum,” Dave Skibinski, president and CEO of SnapMD, said in a statement. “Our telemedicine software will now provide Carefluence customers with a true point-of-care solution for virtual care interactions.”